BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 35008734)

  • 1. E2f2 Attenuates Apoptosis of Activated T Lymphocytes and Protects from Immune-Mediated Injury through Repression of Fas and FasL.
    Mustafa N; Mitxelena J; Infante A; Zenarruzabeitia O; Eriz A; Iglesias-Ara A; Zubiaga AM
    Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008734
    [TBL] [Abstract][Full Text] [Related]  

  • 2. T cell receptor ligation triggers novel nonapoptotic cell death pathways that are Fas-independent or Fas-dependent.
    Davidson WF; Haudenschild C; Kwon J; Williams MS
    J Immunol; 2002 Dec; 169(11):6218-30. PubMed ID: 12444127
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fas-FasL interaction in cytotoxic T cell-mediated vitiligo: The role of lesional expression of tumor necrosis factor-α and interferon-γ in Fas-mediated melanocyte apoptosis.
    Jimbo H; Nagai H; Fujiwara S; Shimoura N; Nishigori C
    Exp Dermatol; 2020 Jan; 29(1):61-70. PubMed ID: 31675451
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Myeloid-derived suppressor cells express the death receptor Fas and apoptose in response to T cell-expressed FasL.
    Sinha P; Chornoguz O; Clements VK; Artemenko KA; Zubarev RA; Ostrand-Rosenberg S
    Blood; 2011 May; 117(20):5381-90. PubMed ID: 21450901
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of cell surface expression of Fas (CD95) ligand and susceptibility to Fas (CD95)-mediated apoptosis in activation-induced T cell death involves calcineurin and protein kinase C, respectively.
    Tóth R; Szegezdi E; Molnár G; Lord JM; Fésüs L; Szondy Z
    Eur J Immunol; 1999 Feb; 29(2):383-93. PubMed ID: 10064053
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fas/FasL Signaling Regulates CD8 Expression During Exposure to Self-Antigens.
    Flores-Mendoza G; Rodríguez-Rodríguez N; Rubio RM; Madera-Salcedo IK; Rosetti F; Crispín JC
    Front Immunol; 2021; 12():635862. PubMed ID: 33841416
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HSV-2 regulates monocyte inflammatory response via the Fas/FasL pathway.
    Krzyzowska M; Baska P; Orlowski P; Zdanowski R; Winnicka A; Eriksson K; Stankiewicz W
    PLoS One; 2013; 8(7):e70308. PubMed ID: 23922974
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Membrane-bound Fas ligand only is essential for Fas-induced apoptosis.
    O' Reilly LA; Tai L; Lee L; Kruse EA; Grabow S; Fairlie WD; Haynes NM; Tarlinton DM; Zhang JG; Belz GT; Smyth MJ; Bouillet P; Robb L; Strasser A
    Nature; 2009 Oct; 461(7264):659-63. PubMed ID: 19794494
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suppression of FasL expression in tumor cells and preventing TNF-induced apoptosis was better for immune cells survival.
    Xu G; Zhang J
    J Cancer Res Clin Oncol; 2008 Oct; 134(10):1043-9. PubMed ID: 18461366
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The critical role of protein kinase C-theta in Fas/Fas ligand-mediated apoptosis.
    Manicassamy S; Sun Z
    J Immunol; 2007 Jan; 178(1):312-9. PubMed ID: 17182568
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Th17 cells undergo Fas-mediated activation-induced cell death independent of IFN-gamma.
    Zhang Y; Xu G; Zhang L; Roberts AI; Shi Y
    J Immunol; 2008 Jul; 181(1):190-6. PubMed ID: 18566384
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proteasome inhibitors block Ras/ERK signaling pathway resulting in the downregulation of Fas ligand expression during activation-induced cell death in T cells.
    Tanimoto Y; Kizaki H
    J Biochem; 2002 Mar; 131(3):319-26. PubMed ID: 11872160
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disruption of the MDM2-p53 interaction strongly potentiates p53-dependent apoptosis in cisplatin-resistant human testicular carcinoma cells via the Fas/FasL pathway.
    Koster R; Timmer-Bosscha H; Bischoff R; Gietema JA; de Jong S
    Cell Death Dis; 2011 Apr; 2(4):e148. PubMed ID: 21509038
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immune modulation by Fas ligand reverse signaling: lymphocyte proliferation is attenuated by the intracellular Fas ligand domain.
    Lückerath K; Kirkin V; Melzer IM; Thalheimer FB; Siele D; Milani W; Adler T; Aguilar-Pimentel A; Horsch M; Michel G; Beckers J; Busch DH; Ollert M; Gailus-Durner V; Fuchs H; Hrabe de Angelis M; Staal FJ; Rajalingam K; Hueber AO; Strobl LJ; Zimber-Strobl U; Zörnig M
    Blood; 2011 Jan; 117(2):519-29. PubMed ID: 20971954
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of fas ligand expression during activation-induced cell death in T cells by p38 mitogen-activated protein kinase and c-Jun NH2-terminal kinase.
    Zhang J; Gao JX; Salojin K; Shao Q; Grattan M; Meagher C; Laird DW; Delovitch TL
    J Exp Med; 2000 Mar; 191(6):1017-30. PubMed ID: 10727463
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interleukin-6 (IL-6) prevents activation-induced cell death: IL-2-independent inhibition of Fas/fasL expression and cell death.
    Ayroldi E; Zollo O; Cannarile L; D' Adamio F; Grohmann U; Delfino DV; Riccardi C
    Blood; 1998 Dec; 92(11):4212-9. PubMed ID: 9834226
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cell death induced by the Fas/Fas ligand pathway and its role in pathology.
    Waring P; Müllbacher A
    Immunol Cell Biol; 1999 Aug; 77(4):312-7. PubMed ID: 10457197
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide inhibit antigen-induced apoptosis of mature T lymphocytes by inhibiting Fas ligand expression.
    Delgado M; Ganea D
    J Immunol; 2000 Feb; 164(3):1200-10. PubMed ID: 10640731
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NF-kappaB regulates Fas/APO-1/CD95- and TCR- mediated apoptosis of T lymphocytes.
    Dudley E; Hornung F; Zheng L; Scherer D; Ballard D; Lenardo M
    Eur J Immunol; 1999 Mar; 29(3):878-86. PubMed ID: 10092091
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activated cytotoxic lymphocytes promote tumor progression by increasing the ability of 3LL tumor cells to mediate MDSC chemoattraction via Fas signaling.
    Yang F; Wei Y; Cai Z; Yu L; Jiang L; Zhang C; Yan H; Wang Q; Cao X; Liang T; Wang J
    Cell Mol Immunol; 2015 Jan; 12(1):66-76. PubMed ID: 24769795
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.